NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

Figures
Tables
Acronyms and abbreviations
KDOQI advisory board members
Work group and evidence review team membership and support group

Part 1. Executive Summary

Part 2. Background

Part 3. Chronic kidney disease as a public health problem

Part 4. Definition and classification of stages of chronic kidney disease

Guideline 1. Definition and Stages of Chronic Kidney Disease
Guideline 2. Evaluation and Treatment
Guideline 3. Individuals at Increased Risk of Chronic Kidney Disease

Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease

Guideline 4. Estimation of GFR
Guideline 5. Assessment of Proteinuria
Guideline 6. Markers of Chronic Kidney Disease Other Than Proteinuria

Part 6. Association of level of GFR with complications in adults

Guideline 7. Association of Level of GFR With Hypertension
Guideline 8. Association of Level of GFR With Anemia
Guideline 9. Association of Level of GFR With Nutritional Status
Guideline 10. Association of Level of GFR With Bone Disease and Disorders of Calcium and Phosphorus Metabolism
Guideline 11. Association of Level of GFR With Neuropathy
Guideline 12. Association of Level of GFR With Indices of Functioning and Well-Being

Part 7. Stratification of risk for progression of kidney disease and development of cardiovascular disease

Guideline 13. Factors Associated With Loss of Kidney Function in Chronic Kidney Disease
Guideline 14. Association of Chronic Kidney Disease With Diabetic Complications
Guideline 15. Association of Chronic Kidney Disease With Cardiovascular Disease

Part 8. Recommendations for clinical performance measures

Part 9. Approach to chronic kidney disease using these guidelines

Part 10. Appendices

Appendix 1. Methods for Review of Articles
Appendix 2. Kidney Function and Associated Conditions in the United States: Methods and Findings From the Third National Health and Nutrition Examination Survey (1988 to 1994)
Appendix 3. Methodological Aspects of Evaluating Equations to Predict GFR and Calculations Using 24-Hour Urine Samples

Part 11. Work group members

Part 12. Acknowledgements